| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of Transcatheter Aortic Valve Replacement in a patient with Familial Hypercholesterolemia
|
Bekele, Nathan
|
|
|
14 |
4 |
p. 568-569
|
artikel
|
| 2 |
A Clinical Decision Support Tool for the Detection and Treatment of Familial Hypercholesterolemia
|
Bangash, Hana
|
|
|
14 |
4 |
p. 554-555
|
artikel
|
| 3 |
An Approach to PCSK9-inhibitor Non-Responders- A Case Series
|
De Jesus, Sasha
|
|
|
14 |
4 |
p. 604-605
|
artikel
|
| 4 |
Are statins safe in patients with COVID-19?
|
Karalis, Dean G.
|
|
|
14 |
4 |
p. 396-397
|
artikel
|
| 5 |
Arterial stiffness improvement after adding on PCSK9 inhibitors in patients with familial hypercholesterolemia
|
Papaioannou, Theodore G.
|
|
|
14 |
4 |
p. 542
|
artikel
|
| 6 |
A Simplified Diagnosis Algorithm for Dysbetalipoproteinemia
|
Baass, Alexis
|
|
|
14 |
4 |
p. 586
|
artikel
|
| 7 |
A simplified diagnosis algorithm for dysbetalipoproteinemia
|
Paquette, Martine
|
|
|
14 |
4 |
p. 431-437
|
artikel
|
| 8 |
Assessment of the JACC 2018 Recommendations for Genetic Testing for Familial Hypercholesterolemia: A Tertiary Care Center’s Experience
|
Brown, Emily
|
|
|
14 |
4 |
p. 597-598
|
artikel
|
| 9 |
Association of Serum Vitamins, Minerals, and Heavy Metals with Lipoprotein(a)
|
Brandt, Eric
|
|
|
14 |
4 |
p. 560
|
artikel
|
| 10 |
Author's reply to: Arterial stiffness improvement after adding on PCSK9 inhibitors in patients with familial hypercholesterolemia, a letter from Papaioannou and colleagues
|
Mandraffino, Giuseppe
|
|
|
14 |
4 |
p. 543
|
artikel
|
| 11 |
Authors’ response to letter by Fogacci, Borghi, and Cicero, “Misinterpreting data in lipidology in the era of COVID-19”
|
Cao, Xiaoling
|
|
|
14 |
4 |
p. 544-545
|
artikel
|
| 12 |
Autosomal recessive hypercholesterolemia in a kindred of Syrian ancestry
|
Martinsen, Morten Hostrup
|
|
|
14 |
4 |
p. 419-424
|
artikel
|
| 13 |
A Virtual Reality in Practice View: Decreasing Cardiovascular Risk for Patients with Persistent Hypercholesterolemia
|
Hanson, Brianna
|
|
|
14 |
4 |
p. 552-553
|
artikel
|
| 14 |
Bempedoic Acid and Glycemic Control: A Pooled Analysis of 4 Phase 3 Clinical Trials
|
Leiter, Lawrence
|
|
|
14 |
4 |
p. 577-579
|
artikel
|
| 15 |
Bempedoic Acid Efficacy and Safety in High CVD Risk Patients Treated With or Without Ezetimibe: Pooled Analysis of 4 Phase 3 Clinical Trials†
|
Catapano, Alberico
|
|
|
14 |
4 |
p. 569-570
|
artikel
|
| 16 |
BIO89-100, a GlycoPEGylated FGF21 Analog, Improved Serum Lipids and Extended Half-Life in a Controlled Single Ascending Dose Trial in Healthy Subjects†
|
Margalit, Maya
|
|
|
14 |
4 |
p. 585-586
|
artikel
|
| 17 |
BIO89-100, a novel glycoPEGylated FGF21 Analog, Demonstrates Triglyceride Reduction and Broad Metabolic Effects in Spontaneously Diabetic Obese Cynomolgus Monkeys
|
Pierce, Andrew
|
|
|
14 |
4 |
p. 584-585
|
artikel
|
| 18 |
Both Cardiologists and Primary Care Physicians Lack Awareness in How to Recognize and Treat Heterozygous Familial Hypercholesterolemia†
|
Karalis, Dean
|
|
|
14 |
4 |
p. 562-563
|
artikel
|
| 19 |
Cardiovascular Risk Assessment in Patients with Diabetes Mellitus and Familial Hypercholesterolemia
|
Agarwala, Anandita
|
|
|
14 |
4 |
p. 559-560
|
artikel
|
| 20 |
Case Report: Acute Stroke Due to Cerebrovascular Atherosclerosis in Chinese-american Woman with Extremely High Level of High Density Lipoprotein-cholesterol (HDL-C) and Coronary Artery Calcium Score Equal Zero
|
Gong, Jan
|
|
|
14 |
4 |
p. 572
|
artikel
|
| 21 |
Clinical Limitations of Genotyping-Versus Sequencing-Based Strategies for Familial Hypercholesterolemia†
|
Callis, Tom
|
|
|
14 |
4 |
p. 573-574
|
artikel
|
| 22 |
Clinical Utility of Expanded Pan Dyslipidemia and Statin-Induced Myopathy Genetic Testing
|
Jaremko, Malgorzata
|
|
|
14 |
4 |
p. 593
|
artikel
|
| 23 |
Comparing Eicosapentaenoic Acid Between Plasma and Serum from a Randomized-Controlled Clinical Trial
|
Dunbar, Richard
|
|
|
14 |
4 |
p. 582
|
artikel
|
| 24 |
Comparison of the Effect of Hypertriglyceridemia on Non-HDL-Cholesterol and Apolipoprotein B as Cardiovascular Disease Risk Markers∗,†
|
Sun, Cathy
|
|
|
14 |
4 |
p. 571-572
|
artikel
|
| 25 |
Comparison of Two Methods for Assessing Small, Dense LDL Cholesterol
|
Wilcox, Meredith
|
|
|
14 |
4 |
p. 567-568
|
artikel
|
| 26 |
Contrasting Postprandial Triglyceride Response of Two Niacin Formulations and Regimen To Modify Coronary Heart Disease Risk
|
Ueda, Masako
|
|
|
14 |
4 |
p. 566-567
|
artikel
|
| 27 |
Development of a Novel Patient-Reported Outcome Measure for Symptoms and Impacts of Familial Chylomicronemia Syndrome
|
Davidson, David
|
|
|
14 |
4 |
p. 571
|
artikel
|
| 28 |
Differential Effects of EPA, DHA, and DPA on Membrane Structure and Stability
|
Mason, Preston
|
|
|
14 |
4 |
p. 576-577
|
artikel
|
| 29 |
Differential Effects of EPA, DPA, and DHA in Inhibiting Oxidation of Low-Density Lipoproteins and Very-Low-Density Lipoproteins in Vitro
|
Mason, Preston
|
|
|
14 |
4 |
p. 576
|
artikel
|
| 30 |
Disclosure of s Genetic Risk Variant to Familial Hypercholesterolemia Improves Adherence to Lipid Lowering Therapy
|
Jones, Laney
|
|
|
14 |
4 |
p. 563-564
|
artikel
|
| 31 |
Discovery of Novel Brown Adipokines that Lower Lipid During Glucose Management Under Insulin Resistance
|
Tanataweethum, Nida
|
|
|
14 |
4 |
p. 582-583
|
artikel
|
| 32 |
Double Heterozygosity of ApoA5 Causing Familial Chylomicronemia Syndrome
|
Trippi, James
|
|
|
14 |
4 |
p. 549-550
|
artikel
|
| 33 |
Early Statin Use and Recurrent Major Adverse Cardiovascular Events: A Multicenter Study
|
Tecson, Kristen
|
|
|
14 |
4 |
p. 561
|
artikel
|
| 34 |
Editorial Board
|
|
|
|
14 |
4 |
p. A1-A4
|
artikel
|
| 35 |
Effects of Different Chemical fFrms of EPA and DHA on the Omega-3 Index: A Meta-Analysis of 16 Trials
|
Harris, William
|
|
|
14 |
4 |
p. 589-590
|
artikel
|
| 36 |
Effects of EPA+DHA Combination on Cardiovascular Outcomes: A Meta-Analysis
|
Rahman, Hammad
|
|
|
14 |
4 |
p. 549
|
artikel
|
| 37 |
Effects of Novel Biologics to Treat Hypertriglyceridemia in Familial Chylomicronemia Syndrome with Two Different Genotypes
|
Ueda, Masako
|
|
|
14 |
4 |
p. 590-591
|
artikel
|
| 38 |
Efficacy and Safety of Bempedoic Acid in Elderly Patients: Pooled Analyses from Phase 3 Trials
|
Mancini, G.B.
|
|
|
14 |
4 |
p. 583
|
artikel
|
| 39 |
Eicosapentaenoic Acid Maintains Normal Membrane Cholesterol Distribution under Hyperglycemic Conditions unlike a Mixed Omega-3 Fatty Acid Supplement
|
Mason, Preston
|
|
|
14 |
4 |
p. 574-575
|
artikel
|
| 40 |
Elucidating the Link Between Alcohol and HDL Metabolism in the Multiethnic Dallas Heart Study
|
Badia, Rohit
|
|
|
14 |
4 |
p. 596-597
|
artikel
|
| 41 |
Extreme Hypercholesterolemia in 3 Patients on Very Low Carbohydrate Diets
|
Schaffer, Anna
|
|
|
14 |
4 |
p. 580
|
artikel
|
| 42 |
Factors that Influence Bempedoic Acid-Mediated Reductions in High-sensitivity C reactive Protein: Analysis of Pooled Patient-level Data from Phase 3 Clinical Trials†
|
Stroes, Erik
|
|
|
14 |
4 |
p. 577
|
artikel
|
| 43 |
Familial Partial Lipodystrophy Due to a Mutation in Pparg Resulting in Severe Hypertriglyceridemia, Hepatosteatosis and Insulin Resistance
|
Bajaj, Archna
|
|
|
14 |
4 |
p. 567
|
artikel
|
| 44 |
Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle-aged Japanese men
|
Hirayama, Satoshi
|
|
|
14 |
4 |
p. 522-530
|
artikel
|
| 45 |
First Results of RNA Interference Against Apolipoprotein C3 as a Treatment for Chylomicronemia
|
Clifton, Peter
|
|
|
14 |
4 |
p. 594
|
artikel
|
| 46 |
Free fatty acids, cardiovascular disease, and mortality in the Multi-Ethnic Study of Atherosclerosis
|
Nomura, Sarah O.
|
|
|
14 |
4 |
p. 531-541
|
artikel
|
| 47 |
From the editor: Never send to know for whom the bell tolls
|
Guyton, John R.
|
|
|
14 |
4 |
p. 381-382
|
artikel
|
| 48 |
GBinsight Comprehensive Dyslipidemia Genetic Analysis Demonstrates High Concordance Between Clinical Diagnosis and Genetic Findings
|
Roth, Mendel
|
|
|
14 |
4 |
p. 594-595
|
artikel
|
| 49 |
Gene–environment interaction between APOA5 c.553G>T and pregnancy in hypertriglyceridemia-induced acute pancreatitis
|
Pu, Na
|
|
|
14 |
4 |
p. 498-506
|
artikel
|
| 50 |
Genetic Analysis Identifies APOE-Opathies that Mask Other Dyslipidemias
|
Roth, Mendel
|
|
|
14 |
4 |
p. 595
|
artikel
|
| 51 |
Genetic Testing for Hypertriglyceridemia--Experience From a Single Center Lipid Clinic∗
|
Hadley, Trevor
|
|
|
14 |
4 |
p. 608-610
|
artikel
|
| 52 |
Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association
|
Brown, Emily E.
|
|
|
14 |
4 |
p. 398-413
|
artikel
|
| 53 |
Genetic Testing in Patients with High Lipoprotein(a): Experience from the UCSD Lipoprotein(a) Specialty Clinic
|
Epstein, Elizabeth
|
|
|
14 |
4 |
p. 601-603
|
artikel
|
| 54 |
Genetic variants in SUSD2 are associated with the risk of ischemic heart disease
|
Bruikman, Caroline S.
|
|
|
14 |
4 |
p. 470-481
|
artikel
|
| 55 |
Heterogeneity of Diabetic Dyslipidemia, Data from the NHANES (2011-2016)
|
Li, Yanshuang
|
|
|
14 |
4 |
p. 588
|
artikel
|
| 56 |
High Body Mass Index and Low HDL Interaction Affects Pulse Wave Velocity in Youth: the SHIP AHOY Study
|
Urbina, Elaine
|
|
|
14 |
4 |
p. 546-547
|
artikel
|
| 57 |
High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia
|
White, Zoe
|
|
|
14 |
4 |
p. 459-469.e0
|
artikel
|
| 58 |
How does Burden of Illness of Familial Chylomicronemia Syndrome Patients Compare to a General Population cohort? Results of a PSM study
|
Davidson, Michael
|
|
|
14 |
4 |
p. 548-549
|
artikel
|
| 59 |
Icosapent Ethyl Mitigates Dyslipidemia by Both Hastening LDL Clearance and Slowing Triglyceride-Rich Lipoprotein Production
|
Dunbar, Richard
|
|
|
14 |
4 |
p. 566
|
artikel
|
| 60 |
Identification and Management of Familial Hypercholesterolemia in an Integrated Health Care Delivery System
|
Birnbaum, Richard
|
|
|
14 |
4 |
p. 600
|
artikel
|
| 61 |
Identification of a Novel APOB Mutation in a Patient with Lifelong Hypercholesterolemia
|
Miller, Meghan
|
|
|
14 |
4 |
p. 593-594
|
artikel
|
| 62 |
Impact of Simulation-Based CME on Clinicians; Knowledge and Competence Related to the Management of Elevated LDL-C
|
Karandrea, Shpetim
|
|
|
14 |
4 |
p. 574
|
artikel
|
| 63 |
Importance of the Triglyceride Level in the Identification of Patients with a Type III Hyperlipoproteinemia Phenotype using the ApoB Method
|
Varghese, Bibin
|
|
|
14 |
4 |
p. 559
|
artikel
|
| 64 |
Improving Identification and Treatment of Primary and Secondary Hyperlipidemia for Young Women at a Large Health System
|
Lewey, Jennifer
|
|
|
14 |
4 |
p. 597
|
artikel
|
| 65 |
JCL roundtable: Low-carbohydrate diets
|
Boucher, Jackie L.
|
|
|
14 |
4 |
p. 384-395
|
artikel
|
| 66 |
Ketogenic Diet Causing Severe Hypercholesterolemia in Former Athlete
|
Smith, Cara
|
|
|
14 |
4 |
p. 569
|
artikel
|
| 67 |
Lipid Abnormalities in Thyroid Dysfunction∗, †
|
Franco, Luiz
|
|
|
14 |
4 |
p. 565-566
|
artikel
|
| 68 |
Lipid Lowering Treatment Patterns and Risk of Subsequent Cardiovascular Outcomes Among Patients Initially Rejected for pcsk9 Inhibitor Therapy
|
Desai, Nihar
|
|
|
14 |
4 |
p. 599-600
|
artikel
|
| 69 |
Lipid Screening Patterns in an Urban Population
|
Gopal, Dipika
|
|
|
14 |
4 |
p. 605-606
|
artikel
|
| 70 |
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a)
|
Stefanutti, Claudia
|
|
|
14 |
4 |
p. 487-497.e1
|
artikel
|
| 71 |
Low Alpha1/Alpha3 HDL subclass Ratio Predicts Progression of Coronary Plaque Volumes by Coronary Computed Tomography Angiography (CCTA): EVAPORATE Trial
|
Lakshmanan, Suvasini
|
|
|
14 |
4 |
p. 591-592
|
artikel
|
| 72 |
Low-Density Lipoprotein-Cholesterol Lowering in Patients with a Recent Myocardial Infarction and Subsequent Treatment with Evolocumab in Real-World Clinical Practice
|
Desai, Nihar
|
|
|
14 |
4 |
p. 551-552
|
artikel
|
| 73 |
Low levels of cholesterol and the cholesterol type are not associated with depression: Results of a cross-sectional NHANES study
|
Cepeda, M. Soledad
|
|
|
14 |
4 |
p. 515-521
|
artikel
|
| 74 |
Metformin Inhibition of Volume Expansion with Cholesterol Crystallization May Contribute to Reducing Plaque Rupture and Improved Cardiac Outcomes
|
Boumegouas, Manel
|
|
|
14 |
4 |
p. 579-580
|
artikel
|
| 75 |
Misinterpreting data in lipidology in the era of COVID-19
|
Fogacci, Federica
|
|
|
14 |
4 |
p. 543-544
|
artikel
|
| 76 |
Modulation of Cardiovascular Risk by Monogenic and Polygenic Determinants of Low-Density Lipoprotein Cholesterol^
|
Trinder, Mark
|
|
|
14 |
4 |
p. 555-556
|
artikel
|
| 77 |
New from NLA July/Aug
|
|
|
|
14 |
4 |
p. 383
|
artikel
|
| 78 |
Nonalcoholic Fatty Liver Disease in Children and Adolescent with Overweight and Obesity: a Retrospective Cohort Study
|
St-Pierre, Julie
|
|
|
14 |
4 |
p. 606-607
|
artikel
|
| 79 |
Non-Responders to Treatment with PCSK9 Inhibitors: a Tale of Two FH Patients
|
Jones, Laney
|
|
|
14 |
4 |
p. 600-601
|
artikel
|
| 80 |
Online CME Effectively Improves Understanding and Application of Lipid Management Guidelines
|
Larkin, Amy
|
|
|
14 |
4 |
p. 548
|
artikel
|
| 81 |
Perceptions and Barriers on the Use of PCSK9 Inhibitors in Heterozygous Familial Hypercholesterolemia
|
Bang, Matthew
|
|
|
14 |
4 |
p. 586-587
|
artikel
|
| 82 |
Physician Characteristics and Attitudes towards Lipid-Lowering Treatment and Variability in Implementation of Guidelines: Insights from the Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD) Reg
|
Al Rifai, Mahmoud
|
|
|
14 |
4 |
p. 607-608
|
artikel
|
| 83 |
Post Coronary Artery Bypass Graft (CABG) Lipid Optimization Trial
|
Ben-Ami, Johanna
|
|
|
14 |
4 |
p. 558-559
|
artikel
|
| 84 |
Prevalence and Treatment of Familial Hypercholesterolemia According to the Dutch Lipid Clinic Network Score (DLCNS): a Retrospective, Single Centered
|
Gokhale, Sanket
|
|
|
14 |
4 |
p. 553-554
|
artikel
|
| 85 |
Primary Care Physician and Cardiologist Cascade Screening Behaviors and Treatment Recommendations for Patients with Familial Hypercholesterolemia
|
Peterson, Amy
|
|
|
14 |
4 |
p. 563
|
artikel
|
| 86 |
Primary Care Physician and Cardiologist Characteristics Predicting Diagnosis and Treatment of Patients with Familial Hypercholesterolemia
|
Block, Robert
|
|
|
14 |
4 |
p. 570
|
artikel
|
| 87 |
PROMIS Measure Captures Perceived Cognitive Impairment Associated with Familial Chylomicronemia Syndrome
|
Fox, Rina
|
|
|
14 |
4 |
p. 561-562
|
artikel
|
| 88 |
Providers Prescribing Behavior for Lipid-lowering Therapy after Receiving Patients Positive Genetic Test for Familial Hypercholesterolemia†
|
Hao, Jing
|
|
|
14 |
4 |
p. 572-573
|
artikel
|
| 89 |
Quantile-specific heritability of high-density lipoproteins with implications for precision medicine
|
Williams, Paul T.
|
|
|
14 |
4 |
p. 448-458.e0
|
artikel
|
| 90 |
Reduced Expression of Angiopoietin-Like Protein 3 via RNA Interference with ARO-ANG3 Produces Prolonged Reductions in LDL-C and Triglycerides in Dyslipidemic Patients
|
Watts, Gerald
|
|
|
14 |
4 |
p. 599
|
artikel
|
| 91 |
Safety, Tolerability, and Pharmacokinetics of Evinacumab, an Angiopoietin-Like Protein 3 Inhibitor, in Healthy Japanese and Caucasian Subjects†
|
Ali, Shazia
|
|
|
14 |
4 |
p. 581
|
artikel
|
| 92 |
Sociodemographic Variations in Prenatal Cholesterol Screening Among Pregnant Women in the United States: The National Health Interview Survey 2012-2018
|
Mszar, Reed
|
|
|
14 |
4 |
p. 556-557
|
artikel
|
| 93 |
Statin use and fall-related hospitalizations among residents of long-term care facilities: A case-control study
|
Wang, Kate N.
|
|
|
14 |
4 |
p. 507-514
|
artikel
|
| 94 |
Strategies to Screen for Familial Hypercholesterolemia among Primary Care Physicians
|
Fishberg, Robert
|
|
|
14 |
4 |
p. 557-558
|
artikel
|
| 95 |
Success of Online CME at Improving Knowledge, Competence, and Confidence Related to Statin Therapy in Patient's with Insulin Resistance
|
Larkin, Amy
|
|
|
14 |
4 |
p. 547-548
|
artikel
|
| 96 |
Table of Contents
|
|
|
|
14 |
4 |
p. A5-A7
|
artikel
|
| 97 |
Temporal decline in non–high-density lipoprotein cholesterol in subjects with diabetes mellitus without atherosclerotic cardiovascular disease
|
Vega, Gloria Lena
|
|
|
14 |
4 |
p. 425-430
|
artikel
|
| 98 |
The Association Between Cancer and Atherosclerosis: Cholesterol Crystal Induced Neovascularization in Breast Cancer
|
Abela, George
|
|
|
14 |
4 |
p. 604
|
artikel
|
| 99 |
The association between triglycerides and incident cardiovascular disease: What is “optimal”?
|
Aberra, Tsion
|
|
|
14 |
4 |
p. 438-447.e3
|
artikel
|
| 100 |
The Efficacy and Safety of Evinacumab in Homozygous Familial Hypercholesterolemia Patients with Little to No Low-Density Lipoprotein Receptor Activity
|
Rosenson, Robert
|
|
|
14 |
4 |
p. 552
|
artikel
|
| 101 |
The first Japanese cases of familial hypercholesterolemia due to a known pathogenic APOB gene variant, c.10580 G>A: p.(Arg3527Gln)
|
Hori, Mika
|
|
|
14 |
4 |
p. 482-486
|
artikel
|
| 102 |
The Impact of Familial Partial Lipodystrophy on Quality of Life from the Patients’ Perspective
|
Oral, Elif
|
|
|
14 |
4 |
p. 590
|
artikel
|
| 103 |
The Montreal-FH-SCORE Predicts Major Adverse Cardiovascular Events in Multinational Cohorts of Familial Hypercholesterolemia
|
Baass, Alexis
|
|
|
14 |
4 |
p. 584
|
artikel
|
| 104 |
The Rationale for an LDL-Cholesterol Goal < 30 mg/dl: Expert Recommendations From the Lipid Association of India
|
Puri, Raman
|
|
|
14 |
4 |
p. 592
|
artikel
|
| 105 |
The Relationship Between Non-HDL-Cholesterol and other Lipid Profile Parameters in Dyslipidemic Subjects
|
Amusat, Saheed
|
|
|
14 |
4 |
p. 550-551
|
artikel
|
| 106 |
The Risk of Cholesterol Crystals on Gap Junction Intercellular Communication in Human Umbilical Vein Endothelial Cells∗
|
Fry, Levi
|
|
|
14 |
4 |
p. 564
|
artikel
|
| 107 |
Twin Pregnancy Normalizes Triglyceride Level in Familial Chylomicronemia Syndrome
|
Ratnani, Pardeep
|
|
|
14 |
4 |
p. 580
|
artikel
|
| 108 |
Use and Variability of Lipoprotein (a) in a Pediatric Lipid Clinic
|
Hamilton, Luke
|
|
|
14 |
4 |
p. 598
|
artikel
|
| 109 |
Use of Lipid-Lowering Therapies in Patients with CKD and ASCVD: A 1-Year Update From GOULD∗
|
Shaik, Aleesha
|
|
|
14 |
4 |
p. 603-604
|
artikel
|
| 110 |
Validation of the Montreal-FH risk score in a United States based cohort of patients with Familial Hypercholesterolemia
|
Agarwala, Anandita
|
|
|
14 |
4 |
p. 568
|
artikel
|
| 111 |
Variability in Content of Omega-3 Fatty Acids and other Fatty Acids in Multiple Lots of a Widely Used Fish Oil Dietary Supplement
|
Mason, Preston
|
|
|
14 |
4 |
p. 575
|
artikel
|
| 112 |
Variability of Response to PCSK9 Inhibitor Therapy
|
Kindig, Erica
|
|
|
14 |
4 |
p. 551
|
artikel
|
| 113 |
When a “normal” cholesterol level is not normal: Exposing an unusual presentation of familial hypercholesterolemia
|
Orringer, Carl E.
|
|
|
14 |
4 |
p. 414-418
|
artikel
|
Tijdschrift beschrijving